Richard Stout
About Richard Stout
Richard Stout serves as the Vice President and Head of Global Sourcing & Procurement at Adaptimmune, bringing extensive experience in the pharmaceutical and biotechnology sectors, particularly in Cell & Gene Therapy. His career includes significant roles at Merck, GSK, and other companies, where he developed strong skills in strategic sourcing and team management.
Current Role at Adaptimmune
Richard Stout serves as the Vice President and Head of Global Sourcing & Procurement at Adaptimmune. He has held this position since 2021, contributing to the company's strategic sourcing initiatives and procurement processes. His role focuses on optimizing the supply chain to support the organization's objectives in the Cell & Gene Therapy industry.
Previous Experience at Adaptimmune
Prior to his current role, Richard Stout worked at Adaptimmune as the Senior Director of Sourcing, Procurement & External Manufacturing from 2017 to 2020. In this capacity, he was responsible for overseeing procurement strategies and managing external manufacturing relationships, ensuring alignment with the company's operational goals.
Career Background in Procurement
Richard Stout has a diverse background in procurement, having worked at several prominent organizations. He served as Associate Director of R&D Procurement at Merck from 2014 to 2015 and as Director of Preclinical Development, Global Clinical Supply, Vaccines & Biologics Procurement from 2015 to 2017. His experience also includes roles at GSK and Schindler Elevator Corporation, where he developed his expertise in strategic sourcing and supply chain management.
Education and Qualifications
Richard Stout earned his MBA from Mount St. Mary's University, completing his studies from 2001 to 2003. His educational background provides a strong foundation for his roles in procurement and supply chain management, particularly within the pharmaceutical and biotechnology sectors.
Expertise in Cell & Gene Therapy
Richard Stout possesses extensive experience in the Cell & Gene Therapy industry, a specialized area within the broader pharmaceutical and biotechnology sectors. His knowledge and skills in this field enhance his ability to lead procurement strategies that support innovative therapies and treatments.